Healthcare AI • Early Detection

Detect the Undetectable.

Rethinking how critical health events are anticipated, not just responded to.

Research-first. Long-term focused. Built for clinical trust.

Request Investor Brief

Private materials shared with qualified investors.

View Pre-Seed Deck

High-level vision and roadmap.

What Current Systems Miss

Most healthcare systems are designed to respond after thresholds are crossed. Subtle changes that precede critical events often go unrecognized. Genesis X is built around the belief that earlier signals exist — but require a fundamentally different approach to detection.

  • Continuous intelligence over episodic measurement
  • Pattern recognition instead of single-point thresholds
  • Privacy-first system architecture
  • Designed to integrate into clinical workflows

Why Early Detection Fails Today

Critical health events rarely arrive without warning. The signals are often there, embedded in subtle physiological shifts that current monitoring approaches are not designed to capture.

The gap is not in technology alone. It is in how we think about risk, when we choose to intervene, and what data we consider meaningful.

Genesis X is exploring whether a different approach to continuous monitoring can meaningfully close that gap.

Pre-Seed Round

Raise Amount

₹1 Crore

Equity Offered

10%

Stage

Pre-Seed

Use of Funds

  • Research and development
  • Prototype exploration
  • Early clinical collaboration
  • Infrastructure and compliance preparation

Founding Team

Harini Sandilyan

Founder & Chief Executive Officer (CEO)

Sathyanarayana Jayakumar

Co-Founder & Chief Technology Officer (CTO)

United by a shared commitment to responsible development in healthcare AI, with a focus on clinical integrity and patient-first design.